FDA inspection
Smithkline Beecham Pharmaceuticals Co.: FDA inspection ending Nov 5, 2004
FDA inspection 356119 · Official Action Indicated (OAI) · Cidra, PR
Key facts
| Inspection ID | 356119 |
|---|---|
| Firm | Smithkline Beecham Pharmaceuticals Co. |
| FEI number | 2650115 |
| Address | Rd 172 Km 9.1, Bo. Certenejas |
| City | Cidra |
| State | PR |
| ZIP | 00739 |
| Fiscal year | 2005 |
| Inspection end date | Nov 5, 2004 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data